Attached files

file filename
EX-10.1 - EXHIBIT 10.1 - TearLab Corpex10-1.htm



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K/A

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

March 4, 2015

 


 

TEARLAB CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-51030

 

59-343-4771

(State or other jurisdiction of 

incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

9980 Huennekens Street, Suite 100

San Diego, CA 92121

(Address of principal executive offices, including zip code)

 

(858) 455-6006

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 

 
 

 

 

Explanatory Note

 

This report amends our Current Report on Form 8-K filed March 10, 2015. The Current Report on Form 8-K filed March 10, 2015 included a Term Loan Agreement as Exhibit 10.1 that is being re-filed herewith to include disclosure of certain financial covenants and revenue milestones that were previously redacted pursuant to a confidential treatment request.

  

Item 9.01 Financial Statements and Exhibits.
   
(d) Exhibits  
   
   
Exhibit No.  Description
   

10.1

Term Loan Agreement, dated as of March 4, 2015, by and among TearLab Corporation, certain of its subsidiaries from time to time party thereto as guarantors and CRG LP (formerly known as Capital Royalty) and certain of its affiliate funds, as lenders.

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

   

TEARLAB CORPORATION

     
 

By: 

/s/ William G. Dumencu

 
   

William G. Dumencu

Chief Financial Officer

 

Date: May 12, 2015